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15TH PATERSON SYMPOSIUM
ANALYSIS OF HAEMOPOIETIC STEM CELL BEHAVIOUR
A REPORT BY R. SCHOFIELD AND B. I. LORD
From the Paterson Laboratories, Manchester H20 9BX
THE MEETING took place in the Holt lecture
theatre of the Paterson Laboratories of the
Christie Hospital & Holt Radium Institute in
Manchester on Thursday and Friday, the 4th
and 5th ofSeptember 1980. Ofthe 34 partici-
pants almost halfwere from abroad (including
Australia, the U.S.A., Canada, France,
Holland, Czechoslovakia and Hungary) whilst
11 of the U.K. participants were members,
visiting fellows or postgraduate students of
the Experimental Haematology Group in
Manchester.
Of the 10 contributions presented on the
first day ofthe symposium, 6 were concerned
with organization of the haemopoietic stem-
cell population which guarantees its continued
functioning throughout the normal lifespan
(and beyond, if this is made possible experi-
mentally). Anyone uninitiated in the pursuit
ofthe haemopoietic stem-cell story could have
been forgiven for comparing it with the search
for a black cat in a dark room. Indeed the
papers described the few clues which their
authors had found, and spent some time
attempting to deduce their meaning.
Hodgson (Melbourne, Australia), who has
collaborated with Bradley, well known for
his studies of CFU-C (in vitro colonies derived
from granulocyte/macrophage precursors),
described further experiments using 5-fluoro-
uracil (FU) injected into mice. This com-
pound reduces the CFU-S (spleen-colony-
forming units=stem cells) population to 400
on injecting the prescribed dose. The clue
obtained from use ofFU is that the surviving
CFU-S form spleen colonies the number of
which increases with time. This is in contrast
to surviving CFU-S after other treatments,
where the number of colonies produced does
not change over an observation period of 5-6
days. The title of "pre-CFU" is given to these
survivors (though sincetheyappeartoproduce
colonies they must, bydefinition, be CFU) and
it is suggested that they produce migrating
colony-forming cells (perbaps in marrow)
which find a resting place in the spleen over a
period of several days. This would cause the
colonies to become macroscopic successively
-the experimental observation. Rosendaal
(University College, London), also using FU
as his starting probe, attempted to demon-
strate that the spleen colonies whichappeared
later had indeed arisen from CFU-S migrating
from marrow. He did this by shielding the
mouse spleen (and whatever else happened to
be covered by the piece of lead used) from
X-rays which irradiated the remainder ofthe
marrow. As a result, there was some fall in the
number oflate spleen colonies developing but
without much more careful experimentation
these data would be difficult (impossible?) to
interpret. Hodgson & Bradley have also
demonstrated cells in the marrow population
surviving FU which produce giant-well,
large-colonies in vitro which appear to arise
from an in vitro colony-forming cell with pro-
liferative capacity much above average. The
general impression from this work is that FU
spares a highly selected fraction of CFU-S,
cells which are indeed at the early maturation
stage. It has yet to be shown that these cells
can actually perform functions which one
might ascribe to the youngest CFU-S.
Hellman (Harvard University, U.S.A.) and
his colleagues have been concerned for the
past few years with the reason for the loss of
proliferative capacity or repopulating ability
ofthe marrow ofanimals (human and rodent)
subjected to cytotoxic agents. They have
formulated a scheme of stem-cell production
which incorporates an age-structure, i.e. a
maturation programme in which loss of
capacity for replication is an inevitable
consequence of replication. In other words,
the scheme embodies a finite, albeit extremely
large, capacity for stem-cell production in the
animal. Under normal conditions, throughout
the lifespan of the mouse an insignificant
(compared with the total available) number
of stem cells is required to function. In orderHAEMOPOIETIC STEM CELLS
to repopulate a haemopoietic tissue depleted
by cytotoxic agents, more are called upon to
proliferate-and therefore become extinct-
producing a loss of repopulating capacity
detectable in these circumstances. General
loss ofreplicating capacity cannot be detected
in untreated mice, and this was explained
away by invoking a "clonal firing" system in
which a few stem cells would become active
sequentially throughout life. Experiments to
substantiate a scheme such as this, or the
alternative hypothesis involving the stem-cell
niche (both of which have something in
common), are very difficult to devise. To dis-
criminate between slow loss of the overall
repopulating ability and the "immortality"
of the stem-cell population may require more
accurate techniques than we have available
at present. The difference may seem un-
important, and until the system is damaged
and asked to repair (perhaps repeatedly)
undoubtedly this is so. It is, however, im-
portant to have the right answer if we wish to
manipulate the ability to recover.
Micklem (University of Edinburgh) re-
duced the CFU-S population by multiple
treatments with hydroxyurea and observed
recovery. In the least damaging regime, he
reported complete recovery after 20 suc-
cessive treatments with the compound, and in
a more severe protocol recovery appeared
complete after 4 treatments, but the experi-
ment had not been continued for longer.
Nevertheless the damage due to hydroxyurea
appears to be qualitatively different from that
caused by (e.g.) myleran, and the patterns of
recovery are both qualitatively and quanti-
tatively different after similar degrees of
depopulation. Harrison (Bar Harbor, U.S.A.)
has published work showing that the cure of
the anaemia in W/Wv mice can be achieved
by serial transplantation of normal marrow
through several generations of anaemic re-
cipients; the limiting factor appeared to be
the damage caused by the mechanics of
transplantation. He presented data from a
study in which he had overcome the trans-
plantation problem by parabiosis of donor
and recipient mice. The coupling of SI/Sld
with W/WV cured the anaemia but the
SI/Sld did not benefit from the collaboration
by improvement in its microenvironment. He
furtherconfirmed theobservations from trans-
plant experiments that the ability of marrow
fromold miceis aseffectivein curingtheW/Wv
anaemia as that of young mice; i.e. he can de-
tect no loss ofrepopulating potential with age.
Feher (Budapest, Hungary) discussed the
possible significance ofthe very small number
ofCFU-S which finds its way into the periph-
eral circulation, and some ofthe factors which
modify this number. The difficulty here is
that there is no evidence of any physiological
significance for these cells, and one felt that
the work may well have little relevance for
normal haemopoiesis.
Two papers touched on the characterization
of the microenvironment required for haemo-
poiesis. (It is regrettable that a third paper
which, along with its author, would have been
of great interest was not presented because
Friedenstein could not make the journey from
the Soviet Union.) Keleman (Budapest,
Hungary) reported microscopic studies ofthe
morphology of colonies produced by injecting
marrow or foetal liver from mice or rats into
syngeneic mice or rats (i.e. syngeneic and
xenogeneic transplants). The dose ofradiation
and the number ofcells injected was shown to
affect the morphology of the cells in clusters,
and the possibility that variation in the
radiation damage to the microenvironment
and to environmental cells transferred with
the graft was speculated upon. This approach,
of course, may give clues but cannot give
answers. On the other hand the work by
Lanotte (Manchester, England) carried out
with Dexter, produces stellate environmental
colonies in cultures of marrow cells grown in
a collagen-gel matrix. Protracted main-
tenance of haemopoiesis is maintained in
these cultures, with the haemopoietic cells
clustered around the fibroblastoid colonies.
Preliminary attempts to clone these putative
environmental cells have so far met with only
limited success.
Loutit (Harwell, England) reported a care-
ful analysis of the WV locus of the mouse by
studying mice with variable genotypes at that
locus. The defects associated with mutations
at the WV locus are foetal inviability, sterility,
absence of melanocytes and defective haemo-
poiesis. Variants ofthe W-defective mice vary
from W itself, in which all 4 functions are
defective, to the WSH-2, in which only coat
colour is abnormal. Furthermore, he showed
that there was considerable variation in the
curability of osteopetrosis in Mi/Mi mice,
which could readily be correlated with the
lesions identified.
The study of molecular events during the
maturation and differentiation of haemo-
943R. SCHOFIELD AND B. I. LORD
poietic progenitor and precursor cells is a
seemingly impossible task, because ofthe very
low concentration of these cells in marrow,
their heterogeneity and the failure to recog-
nize or isolate them. An approach was pre-
sented when Dexter produced a population
of cells (416B) which can be kept in culture
and which was developed from his long-term
marrow cultures as a consequence ofinfecting
with Friend leukaemia virus. These cells,
when injected into heavily irradiated mice,
produce colonies in the spleen. Since this line
was first produced, the pattern ofdifferentia-
tion in the colonies they produce has
changed, though no explanation for this has
been found. Scolnick (Bethesda, U.S.A.), who
has worked extensively with the Harvey and
Kirsten sarcoma viruses, discovered that the
416B cells produce a large amount of a
21,000-dalton protein (p21) related to the
sarc protein produced by Harvey SV. The
amazing finding was that the level in 416B
cells is higher than that in any other known
cell line, fresh or cultured, even when the
cells have been deliberately infected with
HSV. The relationship between 416B and
endogenous production of p21 is not yet
understood. It does not appear to be due to
the proximity of FMuLV (which is present in
416B) to the p21-coding gene. An intriguing
possibility (though not the only one) is that
p21 is massively expressed at a particular
phase ofhaemopoietic stem-cell development.
Unfortunately Scolnick was unable to obtain
data when 416B was apparently at a slightly
different stage of development, as judged by
the differentiation pattern in the spleen
colonies it produces. Further progress can be
expected if Dexter and his collaborators pro-
duce haemopoietic progenitor cell lines at
somewhat different stages of development, or
if 416B continues to change gradually.
This work was exciting, if only because it
heralds a new phase of research in haemo-
poiesis. Haemopoiesis is an area in which
extensive understanding has been achieved
since Till and McCulloch first recognized the
significance of the spleen colonies in 1961.
Considerable advance has been made in
understanding, in cellular terms, what is
happening and what can happen in the
haemopoietic tissues. The next stage, ofwhich
this work is one of the first excursions, is an
attempt to learn how it occurs.
On the 2nd day Le Douarin (Nogent,
France) described her very elegant tech-
niques for analysing the behaviour of stem
cells during the development ofthe lymphoid
system. Using the fact that lymphoid cells
from the chick can be distinguished by both
light and electron microscopes from lymphoid
cells from the quail, she grafted embryonic
thymus from one animal into developing
embryos ofthe other. By careful timing ofthe
grafting procedure she was able to identify
3 waves of chick stem cells seeding into the
quail thymus, and proposed, as a working
hypothesis, that each wave is effected first by
the production ofa diffusible attractant in the
host tissue. This is followed by an invasion of
the thymic rudiments by precursor cells, and
finally the wave is stopped by feedback
inhibition from the differentiated progeny of
the precursors.
A further technical development was
described by Johnson (Melbourne, Australia)
in the growth in vitro of multipotent colony-
forming cells. These are characterized by the
production of mixed cell colonies, and
Johnson demonstrated the pluripotentiality
of the colony-forming cell by replating the
colonies in a secondary culture. Only the
mixed erythroid colonies were capable of
forming further mixed colonies, and they too
always contained erythroid cells, even when
selection pressure against erythropoiesis was
applied. Since erythroid cells were always
present as the progeny of the mixed-colony-
forming cell, and since neither erythropoietin
nor the dispersal of early 4-cell colonies
altered the differentiation patterns, he sug-
gested that potential erythropoiesis is a pre-
determined characteristic of the stem cell.
Paulis (Paris, France) studied the kinetics
of the growth of single-cell megakaryocyte
colonies in culture. He demonstrated that
using polyploidization as his criterion for
measurements it was possible to analyse the
proliferative potential of the cells.
The use ofthe light-activated cell sorter as
a means ofanalysing the properties ofspecific
cell types was introduced by van den Engh
(Rijswijk, The Netherlands). He showed how
it was possible to trace back the history of a
cell, and thus raised the intriguing possibility
that, in theory at least, the sorter could be
used to help resolve some ofthe previous day's
questions with respect to the proposition that
stem-cell proliferation and turnover rates
depend on their cell-cycle history.
Two papers then considered how the
growth ofhaemopoietic tissue can be modified
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by external cellular factors or by processes of
cell-cell interaction. Testa (Manchester)
demonstrated that live thymus cells can
rescue CFU-S from the reduction in spleen-
colony formation produced by rabbit anti-
mouse brain serum. She went on to show that
high-density CFU-S (> 1-075 g/ml) also pro-
duce 3-5 times as many spleen colonies when
injected with thymus cells. Low-density
CFU-S remain unaffected. The possibility of
a modification in spleen seeding efficiency was
excluded. Thymus cells treated with anti-Thy
1.2 did not abrogate the effect, so the co-
operating cell type lies in the minority popu-
lation ofearly T cells, thymic macrophages or
epithelial cells. Moore (New York) con-
sidered the growth and replication of the
committed precursor cell, and demonstrated
the importance of their genetic origin. NZB
mice for example give good colony growth
with L-cell-conditioned medium, while giving
none with WEHI-3CM, which is perfectly
adequate for growth of CBA or NZW CFU-C.
On the other hand, hybrids of NZB with
either CBA or NZW grow perfectly well in
WEHI-3CM. The same patterns held in long-
term "Dexter" cultures, where NZB marrow
will grow on W/Wv adherent layer but not on
a NZB or SI/Sld base. Analysis of W/WV
marrow showed that adherent macrophages
were the cells responsible for promoting NZB
precursor-cell replication.
A session of 3 papers followed, attempting
to understand the mechanisms of CFU-S
proliferation control. Lord (Manchester) dis-
cussed the nature of production of his CFU-S
proliferation inhibitor and stimulator. He
showed that while the appropriate producer
cells are capable ofactively synthesizing their
respective factors, they cannot produce them
in the presence of the opposing factor. At the
same time, the two factors are not mutually
destructive. Thus, a scheme was evolved in
which the relative proximity to, and concen-
tration of, producer cells could enable the
interaction of inhibitor and stimulator to
regulate the size of the CFU-S population.
Neuwirt (Prague, Czechoslovakia) used
hydroxyurea to induce a narrow cohort of
CFU-S to enter DNA synthesis. He then
demonstrated that plasma collected 2-4 h
after the onset of DNA synthesis contained
an inhibitor which, if injected shortly after
the hydroxyurea, prevented the recruitment
of that cohort of CFU-S. These results were
thus compatible with the suggestion that
inhibitor production is induced by the onset
ofDNA synthesis in the CFU-S compartment.
Blackett (Sutton, England) took, as a starting
point, that tissue recovery after a cytotoxic
insult is the major point ofinterest, and went
on to describe experiments which showed that
cyclophosphamide given 3 days before irradi-
ation enhanced CFU-S recovery (5 days after
irradiation the difference in CFU-S levels was
1000-fold). Similar patterns of recovery were
obtained with different drugs, and clearly the
timing of the interval between drug and
irradiation was critical. By correlating the
number ofCFU-S perfemur with the granulo-
cyte levels in the marrow and with time, he
was able to construct a hysteresis loop (called
by the author a "knot diagram" because one
gets tied in knots trying to decipher it) which
illustrates the principle offeedback regulation
ofCFU-S number, and the size of which indi-
cates the delay in onset ofthe feedback mech-
anism.
The regulation of stem-cell differentiation
presents more serious problems, but was
tackled at this meeting by Frindel (Villejuif,
France). She found that cytosine arabinoside-
damaged marrow released a diffusible sub-
stance which caused the erythroid/granulo-
cytic ratio of cells in spleen colonies to be
increased from 2 (normal marrow graft) to
about 8 (ARA-C-treated marrow graft).
Radiation-damaged marrow produced the
opposite effect, reducing the E/G ratio from 2
to 1-3. These results were interpreted as the
result of a differentiation factor(s), the pro-
duction ofwhich is thought to be independent
of the presence of CFU-S. Furthermore, the
differentiation factor cannot distinguish
between cycling and non-cycling cells. Prob-
lems were raised, however, regarding the
meaning ofdifferentiation, and the distinction
between differentiation and maturation was
discussed.
Jasmin (Villejuif, France) studied the
behaviour of precursor cells in mice infected
with myeloproliferative sarcoma virus
(MPSV). He described the cellular changes in
the marrow and spleen during the course of
infection, and came to the conclusion that the
target cell is very early in the haemopoietic
cell lineage-certainly the earliest erythroid
precursors were affected-and Jasmin
queried whether the developing myelofibrosis
indicated a depletion of the most primitive
stem cells. It was accepted that the early cells
were affected, but the question was whether
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traversing the cell cycle at a normal rate.
Thisagreeswithearlierobservations (Wibe,
1980) of cell cycle phase-dependent in-
activation of proliferating NHIK 3025
cells which are in late S or G2 during
exposure to vincristine. In work with
Chinese hamster cells, Olah et al. (1978)
found that plateau cells were more sensi-
tive to vincristine than exponentially
growing cells.
Fig. 2B shows surviving fractions after
24h exposures of NHIK 3025 cells in
spheroids to 3 concentrations of vincris-
tine. For cell populations from 5 different
depthsinthe spheroid, single-cell surviving
fractions are plotted as a function of the
average distance from the spheroid sur-
face. One can see that the surviving frac-
tions are slightly higher for cells in the
inner region than for cells in the outer
parts of the spheroid. Moreover, survival
values of cell populations exposed as
spheroids to 16 ng/ml vincristine per ml
are very close to the survival values after
4 ng/ml. When spheroids were exposed to
4 ng/ml vincristine or 16 ng/ml in the
same experiment (i.e. using identical
spheroids), single-cell surviving fractions
in the different parts ofthe spheroids after
the two drug concentrations were almost
identical. This can be seen from Fig. 2B,
as survival values indicated by open sym-
bols (circles: 4 ng/ml; triangles: 16 ng/ml)
were measured in the same experiment (as
also for half-filled or filled symbols).
Several different factors may be partly
responsible for the dramatic increase in
drug resistance of cells exposed in spher-
oids over exponentially growing mono-
layers. Such factors may be different shape
of individual cells, different drug uptake,
possible reduction in drug supply to the
inner spheroid cells due to insufficient
penetration ofdrug through the cell mass,
differentmetabolisminspheroidandmono-
layer cells, protection of spheroid cells by
intercellular communication, drug resis-
tance of hypoxic cells, or different cell
kinetic parameters. Hardly any of these
factors could be the only reason for the big
reduction in sensitivity to vincristine.
Although Sutherland et al. (1979) found
reduced uptake of Adriamycin in spher-
oids, they showed explicitly that this was
not the only reason for Adriamycin resis-
tance in the inner spheroid cells, which it
was suggested was due to different meta-
bolic state of the cells, differences in the
microenvironment, or the formation of
different drug products.
The relatively uniform sensitivity to
vincristine through all parts of the
spheroid (Fig. 2B), is interesting in view of
the different sensitivity to Adriamycin of
inner and outer spheroid cells observed by
Sutherland et al. (1979). The fact that all
survival values in the present study were
almost independent of both distance
from the spheroid surface and drug con-
centration, and use ofa very long exposure
time (24 h), rules out the possibility that
resistance to vincristine was entirely due
to reduced penetration of vincristine
through the cell mass. In workwith human
glioma spheroids and vinblastine (which
is closely related to vincristine) Neder-
mann et al. (1980) showed that most ofthe
drug could be found in the outer 100 /tm
of the spheroid after a 15min exposure to
this drug.
The fact that plateau-phase cells ex-
posed in monolayer culture were even
more resistant to vincristine than were
cells exposed in the spheroid (Fig. 2)
indicates that resting cells and/or very
slowly proliferating cells constitute an
extremely resistant subpopulation of cells
in the spheroid. This is in accordance with
the slight increment in surviving fraction
with distance from the spheroid surface
(Fig. 2B) as the fraction of resting cells is
higher in the core than in the outer parts
of the spheroids.
The observed resistance to vincristine
fits well with the reported resistance of
spheroid cells to lethal damage after
highly different treatments as y-irradia-
tion, hyperthermia, lymphocyte toxicity,
and Adriamycin. It might be that these,
cases of resistance to treatments are all
more or less related to the same protective
mechanisms. Generally higher tolerance to
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